COVIDSENS product system.jpg

Malaysian company develops Covid-19 rapid test kits that can deliver results under 20 minutes

KUALA LUMPUR, Feb 26 — A homegrown diagnostic solution start-up has developed a digital rapid Covid-19 test kit — dubbed APTSENS — that can upload test results in real-time with geo-location data to cloud servers via a mobile app.

berita tular.jpg

Kit ujian Covid hanya dalam masa 20 minit

KUALA LUMPUR, 26 Februari – Permulaan penyelesaian diagnostik tempatan telah mengembangkan kit ujian Covid-19 secara cepat dan digital – yang diberi nama APTSENS – yang dapat memuat naik hasil ujian dalam masa nyata dengan data lokasi geografi ke pelayan awan (cloud server) melalui aplikasi mudah alih.




Group photo.HEIC

Biogenes – home-grown diagnostic kit maker hits major milestones

THE PETRI DISH spoke to co-founder CEO of Biogenes Technologies Tang Kok Mun and Chief Commercial Officer, Adrian Joseph on their journey in being the pioneer in “in silico” aptamer design in Malaysia.

APTSENS_Reader Version 2.jpg

Regulatory: The sandbox adventures

A rather different company taking part in NTIS is Biogenes Technologies, which specialises in molecular diagnostics and genomics. The company participated in the programme to conduct validation trials for its digital rapid test kit for Covid-19, named COVIDSENS.


CIP accelerate recipient, Biogenes Technologies develops a digital rapid COVID-19 test kit 

“Although it has been extremely challenging for Biogenes to develop this test kit due to the lack of ecosystem in our domestic diagnostic sector, we have been very fortunate to receive support from Malaysian government agencies such as Platcom Ventures, CRADLE and NTIS.

Screen Shot 2020-07-21 at 4.01.17 PM.png

15 new startups that have received funding from Antler

Global startup generator and early-stage VC firm Antler has announced the 15 new companies that have graduated and received investment from its fourth Singapore programme.

Aptamer 01 Pic.jpg

Malaysian companies develop Covid-19 rapid test kits

Homegrown technology company Biogenes Technologies Sdn Bhd is developing an aptamer-based biosensor against the novel coronavirus that can accurately deliver test results in under one minute. 

BH covid 19.webp

COVID-19: Syarikat naungan AIM hasil vaksin, kit ujian

KUALA LUMPUR: Lima syarikat kini dalam pelbagai fasa bagi mengetengahkan produk perubatan untuk pengesanan virus dan klinikal, selain merintis usaha penyelidikan vaksin COVID-19.


Syarikat itu merangkumi Twin Catalyst Sdn Bhd, TTMC Sdn Bhd, Medical Innovation Ventures Sdn Bhd (Mediven), Biogenes Technologies Sdn Bhd dan IN3Bio.


M’sian made aptamer-based biosensor makes its mark

A locally developed aptamer-based biosensor is set to change the way we monitor human body, pathogens, food and environmental contaminants.

bisnes sinar.jpg

AIM Ambil Pendekatan Inovatif Perangi Covid-19 

Agensi Inovasi Malaysia (AIM) melalui empat syarikat Program Berimpak Tinggi 2 (HIP2) di bawah PlaTCOM Ventures Sdn Bhd dan sebuah syarikat pelaburan mengambil pendekatan inovatif untuk memerangi koronavirus (Covid-19) dengan menghasilkan produk perubatan dan klinikal selain memulakan penyelidikan vaksin.

Syarikat tersebut ialah Twin Catalyst Sdn Bhd, TTMC Sdn Bhd, Medical Innovation Ventures Sdn Bhd (Mediven), Biogenes Technologies Sdn Bhd dan IN3Bio.

Group photo.HEIC

15 Startups graduated from Antler's fourth Singapore cohort and COVID-19 Initiative

Bio Genes: A startup that produces aptamer-based (synthetic antibody) diagnostics products via an in-house proprietary technology platform.

biogenesis petri dish.jpg

Biogenes signs exclusive licensing agreement with IUKL

BANGI: Bioegenes Technologies Sdn Bhd (Biogenes), a Malaysian-based company in the field of molecular diagnostics and genomics has signed a licensing agreement with Infrastructure University Kuala Lumpur (IUKL) to commercialise Aptamer technology.


Antibodies, aptamer & a kinder approach

The very nature of our technology helps you go outside and try it in the field. 

Pic 3.jpg

Collaborating genomic tech for precision breeding

Monash University Malaysia and Biogenes Technologies Sdn Bhd signed a Memorandum of Agreement (MoA) on collaborative research to develop genomic technologies.